KIORA PHARMACEUTICALS, INC. (KPHMW) Return on equity 2018–2025
KIORA PHARMACEUTICALS, INC. (KPHMW) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-67.2%FY2025 · since FY2018: -121.0% → -67.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -67.2% | -81.1 pp |
| FY2024 | 14.0% | +218.8 pp |
| FY2023 | -204.8% | — |
| FY2021 | -94.5% | -23.9 pp |
| FY2020 | -70.5% | +36.6 pp |
| FY2019 | -107.2% | +13.8 pp |
| FY2018 | -121.0% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More KPHMW financial trends
KPHMW RevenueKPHMW Net incomeKPHMW Net marginKPHMW Gross profitKPHMW Gross marginKPHMW Operating incomeKPHMW Operating marginKPHMW Operating cash flowKPHMW Free cash flowKPHMW Capital expendituresKPHMW Stock buybacksKPHMW Dividends paidKPHMW Total assetsKPHMW Total liabilitiesKPHMW Shareholders’ equityKPHMW overview →